Vélez HA

Idioma: Español
Referencias bibliográficas: 29
Paginas: 345-355
Archivo PDF: 1561.81 Kb.

RESUMEN

La biopsia por aspiración ha sido utilizada por muchos años como herramienta diagnóstica para el cáncer de mama. El presente módulo incluye las recomendaciones para la biopsia por aspiración con aguja fina (BACAF) de mama desarrolladas y aprobadas por el Instituto Nacional de Cáncer en Bethesda, Maryland, Estados Unidos y adaptadas a nuestro medio después de 10 años de experiencia realizando BACAF en el Hospital Pablo Tobón Uribe, la Universidad Pontificia Bolivariana y Dinámica IPS. También se tomaron en cuenta las recomendaciones de clínicos y radiólogos de diferentes centros médicos y universitarios de Medellín y del país.

REFERENCIAS (EN ESTE ARTÍCULO)

1. National Cancer Institute. Final version: The uniform approach to breast fine needle aspiration biopsy. Breast J 1997; 3: 149-168.

2. Koss LG, Woyke S, Olszewski W. Aspiration biopsy: Cytologic interpretation and histologic basis. 2nd ed. New York, 1992; 12-27.

3. Kreuzer G, Boquoi E. Aspiration biopsy cytology, mammography and clinical exploration: a modern set up in diagnosis of tumors of the breast. Acta Cytol 1976; 20: 19-323.

4. Lannin DR, Silverman JF, Walker C, Pories WJ. Costeffectiveness of fine needle biopsy of the breast. Ann Surg 1986; 203: 474-480.

5. Layfield LJ, Parkinson B, Wong J, Giuliano AE, Bassett LE. Mammographically guided fine-needle aspiration biopsy of nonpalpable breast lesions. Can it replace open biopsy? Cancer 1991; 68: 2007-2011.

6. Lee KR, Foster RS, Papillo JL. Fine needle aspiration of the breast. Importance of the aspirator. Acta Cytol 1987; 31: 281-284.

7. Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR Am J Roentgenol 1995; 164: 1111-1113.

8. Liberman L. Dershaw DD Rosen PP, et al. Stereotaxic core biobsy of breast carcinoma: accuracy in predicting invasion. Radiology 1995; 194: 379-381.

9. Linsk J Kreuzer G, Zajicek J. Cytologic diagnosis of mammary tumors from aspiration biopsy smears. II. Studies on 210 fibroadenomas and 210 cases of benign dysplasia. Acta Cytol 1972; 16: 130-138.

10. Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ, et al. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 1995; 332: 1405-1410.

11. Martelli G, Pilotti S, Coopmans de Yoldi G, Viganotti G, Fariselli G, Lepera P, et al. Diagnostic efficacy of physical examination, mammography, fine-needle aspiration cytology (triple-test) in solid breast lumps: an analysis of 1708 consecutive cases. Tumori 1990; 76: 476-479.

12. Maygarden SJ, Novotny DB, Johnson DE, Frable WJ. Subclassification of benign breast disease by fine needle aspiration cytology. Comparison of cytologic and histologic findings in 265 palpable breast masses. Acta Cytol 1994; 38: 115-129.

13. Mitnick JS, Vazquez MF, Harris MN, Roses DF. Differentiation of radial scar from scirrhous carcinoma of the breast: mammographic-pathologic correlation. Radiology 1989; 173: 697-700.

14. Mulford DK, Dawson AE. Atypia in fine needle aspiration cytology of nonpalpable and palpable mammographically detected breast lesions. Acta Cytol 1994; 38: 9-17.

15. Palombini L, Fulciniti F, Vetrani A, De Rosa G, Benedetto G, Zeppa P, et al. Fine-needle aspiration biopsies of breast masses. A critical analysis of 1956 cases in 8 years (1976-1984). Cancer 1988; 61: 2273-2277.

16. Parker SH, Burbank F, Jackman RJ, Aucreman CJ, Cardenosa G, Cink TM, et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 1994; 193: 359-364.

17. Parker SH, Stavros AT, Dennis MA. Needle biopsy techniques. Radiol Clin North Am 1995; 33: 1171-1186.

18. Pennes DR, Naylor B, Rebner M. Fine needle aspiration biopsy of the breast. Influence of the number of passes and the sample size on the diagnostic yield. Acta Cytol 1990; 34: 673-676.

19. Pinder SE, Wencyk P, Sibbering DM, Bell JA, Elston CW, Nicholson R, et al. Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer 1995; 71: 146-149.

20. Porter-Jordan K, Lippman ME. Overview of the biologic markers of breast cancer. Hematol Oncol Clin North Am 1994; 8: 73-100.

21. Ravdin PM, Chamness GC. The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers--a review. Gene 1995; 159: 19-27.

22. Reiner A, Reiner G, Spona J, Teleky B, Kolb R, Holzner JH. Estrogen receptor immunocytochemistry for preoperative determination of estrogen receptor status on fine-needle aspirates of breast cancer. Am J Clin Pathol 1987; 88: 399-404.

23. Robinson IA, McKee G, Nicholson A, D’Arcy J, Jackson PA, Cook MG, et al. Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas. Lancet 1994; 343: 947-949.

24. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol 1991; 15: 209-221.

25. Rotstein S, Nilsson B, Svane G, Gustavson-Kadaka E. Clinical examination, mammographic findings and cytological diagnosis in patients with breast disorders. Results of 9 years’ follow-up. Acta Oncol 1992; 31: 393-397.

26. Silverman J. Breast. In Comprehensive cytopathology. Bibbo M, eds.WB Saunders. Philadelphia 1991; 703-770.

27. Silverman JF, Lannin DR, O’Brien K, Norris HT. The triage role of fine needle aspiration biopsy of palpable breast biopsy of palpable breast masses. Diagnostic accuracy and cost-effectiveness. Acta Cytol 1987; 31: 731-736.

28. Vélez A, Monsalve Y, López E. Comparación entre la técnica de capilaridad y bacat en nódulos de tiroides. Medicina UPB 24(2); 165-170, oct 2005.

29. Abele JS, Wagner LT, Miller TR. Fine-needle aspiration of the breast: cell counts as an illusion of adecuacy. A clinical cytopathologist point of view. Cancer 1998; 84: 319-323.